SLEEP® journal paper shows Oventus ExVent and OnePAP valves used in combination with mandibular advancement splints reduce sleep apnoea for a substantial proportion of patients

Oventus Medical Ltd (ASX: OVN) is pleased to advise that a peer-reviewed paper on Oventus’ clinical data has been published in the scientific journal, SLEEP® this week. 

The paper demonstrates how Oventus’ O2Vent® mandibular advancement splint (MAS), used in combination with valves such as the ExVentTM* and O2Vent® OnePAPTM*, reduces the severity of Obstructive Sleep Apnoea (OSA) to therapeutic levels for a substantial proportion of incomplete/non-responder patients, compared to MAS therapy alone.

To read the publication abstract, click this link

[addtoany]
Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>